JP2019189659A5 - - Google Patents

Download PDF

Info

Publication number
JP2019189659A5
JP2019189659A5 JP2019145655A JP2019145655A JP2019189659A5 JP 2019189659 A5 JP2019189659 A5 JP 2019189659A5 JP 2019145655 A JP2019145655 A JP 2019145655A JP 2019145655 A JP2019145655 A JP 2019145655A JP 2019189659 A5 JP2019189659 A5 JP 2019189659A5
Authority
JP
Japan
Prior art keywords
test
japanese pharmacopoeia
dissolution
tablet
disintegration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019145655A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019189659A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019189659A publication Critical patent/JP2019189659A/ja
Publication of JP2019189659A5 publication Critical patent/JP2019189659A5/ja
Priority to JP2022088148A priority Critical patent/JP7395653B2/ja
Priority to JP2023201576A priority patent/JP2024015097A/ja
Pending legal-status Critical Current

Links

JP2019145655A 2010-07-07 2019-08-07 クエン酸第二鉄を含む錠剤 Pending JP2019189659A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022088148A JP7395653B2 (ja) 2010-07-07 2022-05-31 クエン酸第二鉄を含む錠剤
JP2023201576A JP2024015097A (ja) 2010-07-07 2023-11-29 クエン酸第二鉄を含む錠剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010155290 2010-07-07
JP2010155290 2010-07-07

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018073443A Division JP6571236B2 (ja) 2010-07-07 2018-04-05 クエン酸第二鉄を含む錠剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022088148A Division JP7395653B2 (ja) 2010-07-07 2022-05-31 クエン酸第二鉄を含む錠剤

Publications (2)

Publication Number Publication Date
JP2019189659A JP2019189659A (ja) 2019-10-31
JP2019189659A5 true JP2019189659A5 (enExample) 2020-02-06

Family

ID=45441316

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2011151304A Active JP5167389B2 (ja) 2010-07-07 2011-07-07 クエン酸第二鉄を含む錠剤
JP2012278687A Active JP5902606B2 (ja) 2010-07-07 2012-12-20 クエン酸第二鉄を含む錠剤
JP2016047158A Active JP6321706B2 (ja) 2010-07-07 2016-03-10 クエン酸第二鉄を含む錠剤
JP2018073443A Active JP6571236B2 (ja) 2010-07-07 2018-04-05 クエン酸第二鉄を含む錠剤
JP2019145655A Pending JP2019189659A (ja) 2010-07-07 2019-08-07 クエン酸第二鉄を含む錠剤
JP2022088148A Active JP7395653B2 (ja) 2010-07-07 2022-05-31 クエン酸第二鉄を含む錠剤
JP2023201576A Pending JP2024015097A (ja) 2010-07-07 2023-11-29 クエン酸第二鉄を含む錠剤

Family Applications Before (4)

Application Number Title Priority Date Filing Date
JP2011151304A Active JP5167389B2 (ja) 2010-07-07 2011-07-07 クエン酸第二鉄を含む錠剤
JP2012278687A Active JP5902606B2 (ja) 2010-07-07 2012-12-20 クエン酸第二鉄を含む錠剤
JP2016047158A Active JP6321706B2 (ja) 2010-07-07 2016-03-10 クエン酸第二鉄を含む錠剤
JP2018073443A Active JP6571236B2 (ja) 2010-07-07 2018-04-05 クエン酸第二鉄を含む錠剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022088148A Active JP7395653B2 (ja) 2010-07-07 2022-05-31 クエン酸第二鉄を含む錠剤
JP2023201576A Pending JP2024015097A (ja) 2010-07-07 2023-11-29 クエン酸第二鉄を含む錠剤

Country Status (4)

Country Link
US (1) US20220142926A1 (enExample)
EP (1) EP2594277A4 (enExample)
JP (7) JP5167389B2 (enExample)
WO (1) WO2012005340A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101665968B1 (ko) 2009-07-21 2016-10-13 케릭스 바이오파마슈티컬스 인코포레이티드 구연산철 투여형태
WO2012005340A1 (ja) * 2010-07-07 2012-01-12 日本たばこ産業株式会社 クエン酸第二鉄を含む錠剤
EP3157516A4 (en) * 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
US20210085711A1 (en) * 2017-09-19 2021-03-25 Japan Tobacco Inc. Use of ferric citrate in prevention and/or treatment of iron-deficiency anemia in hypermenorrhea patient and/or patient suffering from hypermenorrhea-associated gynecologic disease

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4022269B2 (ja) * 1995-05-26 2007-12-12 協和醗酵工業株式会社 医薬組成物
US5753706A (en) * 1996-12-16 1998-05-19 Hsu; Chen Hsing Methods for treating renal failure
FR2774291B1 (fr) * 1998-02-03 2000-04-21 Innothera Lab Sa Specialite pharmaceutique sous forme galenique unitaire de comprimes a croquer ou a sucer, comprenant comme principe actif du fer element
WO2000054752A1 (fr) * 1999-03-15 2000-09-21 Kaken Pharmaceutical Co., Ltd. Comprimes a delitement rapide et procede de fabrication
FR2819720B1 (fr) * 2001-01-22 2004-03-12 Fournier Lab Sa Nouveaux comprimes de fenofibrate
KR101011373B1 (ko) 2002-07-11 2011-01-28 비큐론 파마슈티컬스 인코포레이티드 항균작용을 갖는 n-히드록시아미드 유도체
EP1536788A1 (en) * 2002-08-30 2005-06-08 Pharmacia Corporation Pharmaceutical solid dosage forms exhibiting reproductible drug release profile
TWI335218B (en) * 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
ES2395724T3 (es) * 2003-08-20 2013-02-14 Shionogi & Co., Ltd. Nueva composición de recubrimiento
JP4984455B2 (ja) * 2004-08-18 2012-07-25 日本新薬株式会社 二重被覆錠剤
JP2006076971A (ja) * 2004-09-13 2006-03-23 Basf Ag 口腔内崩壊錠
HUE025264T2 (en) * 2005-08-18 2016-02-29 Panion & Bf Biotech Inc Pharmaceutical-grade ferric citrate for medical use
HUE028029T2 (en) * 2006-01-30 2016-11-28 Panion & Bf Biotech Inc Method of treating chronic kidney disease
AR065809A1 (es) * 2007-03-22 2009-07-01 Bristol Myers Squibb Co Formulaciones farmaceuticas que contienen un inhibidor sglt2
GB0714670D0 (en) * 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
JPWO2009057569A1 (ja) * 2007-10-29 2011-03-10 第一三共株式会社 フィルムコーティング製剤
WO2009101940A1 (ja) * 2008-02-11 2009-08-20 Dainippon Sumitomo Pharma Co., Ltd. 溶出性の改善された錠剤
JP2009269874A (ja) * 2008-05-09 2009-11-19 Daido Kasei Kogyo Kk 水性液剤
WO2012005340A1 (ja) * 2010-07-07 2012-01-12 日本たばこ産業株式会社 クエン酸第二鉄を含む錠剤

Similar Documents

Publication Publication Date Title
JP2019189659A5 (enExample)
BRPI0512177A (pt) formulação de liberação modificada de memantina
JP2011509295A5 (enExample)
RU2011138490A (ru) Фармацевтические композиции с мгновенным высвобождением, содержащие оксикодон и налоксон
JP2009525343A5 (enExample)
Roge et al. The enkephalinase inhibitor, acetorphan, in acute diarrhoea: a double-blind, controlled clinical trial versus loperamide
KR950702409A (ko) 방출 조절 모르핀 제제(controlled release morphine preparation)
HRP20161444T1 (hr) Farmaceutski pripravci koji sadrže lokalni anestetik kao što je bupivakain za lokalnu primjenu u usta ili grlo
RU2010116863A (ru) Бупропиона гидробромид и его терапевтические применения
JP2016147915A5 (enExample)
JP2016513736A5 (enExample)
JP2014516942A5 (enExample)
JP2018529742A5 (enExample)
RU2017143849A (ru) Твёрдый состав для перорального применения, содержащий иринотекан, и способ его получения
JP2018527305A5 (enExample)
JP2014533656A5 (enExample)
JP2019500416A (ja) デュタステリド及びプロピレングリコールモノラウレートを含有する医薬組成物及びその調製方法
NZ611026A (en) Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria
JP2018039810A5 (enExample)
CN109789152A (zh) 双组分组合物
FI3345604T3 (fi) Nalmefeeni alkoholikulutuksen vähentämiseksi spesifisissä kohdepopulaatioissa
JP2015521647A5 (enExample)
JP2019520377A5 (enExample)
JP2017508004A5 (enExample)
JP2004522780A5 (enExample)